No abstract

COVID-19 pandemic has made changes to conventional health care. In view of the need for “social distancing”, telemedicine services became most in demand, which constituted a reform of the previous doctor-patient relationship format; dermatology was no exception. Increased use of teledermatology (TD) all over the world elevated the relevance of the set of challenges related to teledermatology potential and limits, particularly in the light of the expectations of the technology broader application during the post-pandemic period. The review addresses the issues related to accounting for quality of health care, understanding the social and humanitarian context of TD, as well as the impact on professional education.

No abstract

In connection with the increasing incidence of patients with skin manifestations of helminth infections after visiting endemic zones, dermatovenereologists need to know the skin manifestation of tropical countries diseases. At present, serpeginating dermatitis often causes difficulties in the diagnosis and choice of treatment tactics. Tissue helminthiasis is a skin disease caused by the parasitization of migratory zohelminth larvae, for which a person is an intermediate host. Infection is most often affected by people who come into contact with warm, moist, sandy soil contaminated by dog and cat feces. This article presents a clinical case of a patient with a diagnosis of the skin form of “larva migrans syndrome” treated with two courses of the anthelmintic drug of the benzimidazole group in a daily dose of 800 mg with regressing the dermatological manifestations of the disease within 2 weeks from the start of specific therapy.

In connection with the increasing incidence of patients with skin manifestations of helminth infections after visiting endemic zones, dermatovenereologists need to know the skin manifestation of tropical countries diseases. At present, serpeginating dermatitis often causes difficulties in the diagnosis and choice of treatment tactics. Tissue helminthiasis is a skin disease caused by the parasitization of migratory zohelminth larvae, for which a person is an intermediate host. Infection is most often affected by people who come into contact with warm, moist, sandy soil contaminated by dog and cat feces. This article presents a clinical case of a patient with a diagnosis of the skin form of “larva migrans syndrome” treated with two courses of the anthelmintic drug of the benzimidazole group in a daily dose of 800 mg with regressing the dermatological manifestations of the disease within 2 weeks from the start of specific therapy.